Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

This publication has 17 references indexed in Scilit:

• Neuroactive substances in the dorsal vagal complex of the medulla oblongata: nucleus of the tractus solitarius, area postrema, and dorsal motor nucleus of the vagus
  Published by Elsevier ,2003
• Enantioselective inhibition of ampomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994
  Neuropharmacology, 1994
• The 5-hydroxytryptamine receptor antagonists as antiemetics: Preclinical evaluation and mechanism of action
  European Journal Of Cancer, 1993
• Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets
  European Journal of Pharmacology, 1993
• The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret
  European Journal of Pharmacology, 1993
• Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret
  Neuropharmacology, 1993
• Investigation into species variants in tachykinin NK₁ receptors by use of the non‐peptide antagonist, CP‐96,345
  British Journal of Pharmacology, 1991
• Subregional topography of capillaries in the dorsal vagal complex of rats: II. Physiological properties
  Journal of Comparative Neurology, 1991
• 5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesis
  Neuropharmacology, 1986
• Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
  Journal of Cerebral Blood Flow & Metabolism, 1983